IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
LOC102723407 |
|
immunoglobulin heavy variable 4-38-2-like
|
|
|
0.514 |
0.769 |
LOC102724971 |
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
|
0.527 |
0.769 |
PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
SOCS3 |
O14543
|
suppressor of cytokine signaling 3
|
Enzyme modulator
|
0.75 |
0.434 |
0.808 |
KMT2D |
O14686
|
lysine methyltransferase 2D
|
|
1.00 |
0.465 |
0.808 |
SOCS1 |
O15524
|
suppressor of cytokine signaling 1
|
Enzyme modulator
|
0.59 |
0.445 |
0.808 |
CXCL13 |
O43927
|
C-X-C motif chemokine ligand 13
|
Signaling
|
0.83 |
0.472 |
0.731 |
JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
PRDM1 |
O75626
|
PR/SET domain 1
|
|
0.96 |
0.538 |
0.731 |
TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
CHEK2 |
O96017
|
checkpoint kinase 2
|
Kinase
|
1.2E-24 |
0.460 |
0.808 |
MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |